Cell-Based Cancer Cure
for Solid Tumors and Hematological Cancers

Cellicure provides innovative, cell-based immunotherapy technologies, customized treatment regimens and real world solutions to solve the current unmet therapeutic needs created by cancer, infectious diseases, and chronic inflammatory diseases.

Cellicure, Inc. is an innovative drug research and development company that focuses on the field of cellular immunotherapy. Cellicure conducts global product development and commercialization for the highly unmet clinical needs caused by cancer, infectious diseases, and chronic inflammatory diseases.

Company Milestone

Gallery

Share this page

Facebook
Twitter
LinkedIn
Email